AngioDynamics Gross Margin 2010-2025 | ANGO
Current and historical gross margin for AngioDynamics (ANGO) over the last 10 years. The current gross profit margin for AngioDynamics as of February 28, 2025 is %.
| AngioDynamics Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-02-28 | $0.28B | $0.16B | 54.77% |
| 2024-11-30 | $0.29B | $0.15B | 53.15% |
| 2024-08-31 | $0.29B | $0.15B | 52.05% |
| 2024-05-31 | $0.30B | $0.16B | 50.99% |
| 2024-02-29 | $0.32B | $0.16B | 50.00% |
| 2023-11-30 | $0.33B | $0.17B | 50.61% |
| 2023-08-31 | $0.34B | $0.17B | 51.19% |
| 2023-05-31 | $0.34B | $0.17B | 51.33% |
| 2023-02-28 | $0.34B | $0.17B | 51.94% |
| 2022-11-30 | $0.33B | $0.17B | 52.44% |
| 2022-08-31 | $0.32B | $0.17B | 52.34% |
| 2022-05-31 | $0.32B | $0.17B | 52.53% |
| 2022-02-28 | $0.31B | $0.16B | 52.94% |
| 2021-11-30 | $0.30B | $0.16B | 53.47% |
| 2021-08-31 | $0.30B | $0.16B | 54.03% |
| 2021-05-31 | $0.29B | $0.16B | 53.95% |
| 2021-02-28 | $0.27B | $0.15B | 53.31% |
| 2020-11-30 | $0.27B | $0.15B | 53.87% |
| 2020-08-31 | $0.27B | $0.15B | 55.22% |
| 2020-05-31 | $0.26B | $0.15B | 56.82% |
| 2020-02-29 | $0.28B | $0.16B | 58.12% |
| 2019-11-30 | $0.27B | $0.16B | 58.24% |
| 2019-08-31 | $0.27B | $0.16B | 57.88% |
| 2019-05-31 | $0.27B | $0.16B | 57.56% |
| 2019-02-28 | $0.21B | $0.13B | 62.62% |
| 2018-11-30 | $0.22B | $0.14B | 60.71% |
| 2018-08-31 | $0.24B | $0.14B | 57.26% |
| 2018-05-31 | $0.26B | $0.14B | 54.58% |
| 2018-02-28 | $0.26B | $0.14B | 52.85% |
| 2017-11-30 | $0.27B | $0.14B | 52.08% |
| 2017-08-31 | $0.27B | $0.14B | 52.43% |
| 2017-05-31 | $0.27B | $0.14B | 53.33% |
| 2017-02-28 | $0.36B | $0.18B | 49.44% |
| 2016-11-30 | $0.36B | $0.18B | 49.30% |
| 2016-08-31 | $0.36B | $0.18B | 49.58% |
| 2016-05-31 | $0.35B | $0.18B | 49.58% |
| 2016-02-29 | $0.35B | $0.18B | 50.57% |
| 2015-11-30 | $0.35B | $0.17B | 48.86% |
| 2015-08-31 | $0.35B | $0.17B | 49.01% |
| 2015-05-31 | $0.36B | $0.18B | 49.44% |
| 2015-02-28 | $0.36B | $0.18B | 50.00% |
| 2014-11-30 | $0.36B | $0.19B | 51.80% |
| 2014-08-31 | $0.36B | $0.18B | 51.40% |
| 2014-05-31 | $0.36B | $0.18B | 50.99% |
| 2014-02-28 | $0.35B | $0.18B | 50.43% |
| 2013-11-30 | $0.35B | $0.17B | 50.14% |
| 2013-08-31 | $0.34B | $0.17B | 50.15% |
| 2013-05-31 | $0.34B | $0.17B | 49.12% |
| 2013-02-28 | $0.31B | $0.16B | 50.00% |
| 2012-11-30 | $0.28B | $0.14B | 51.07% |
| 2012-08-31 | $0.25B | $0.13B | 52.59% |
| 2012-05-31 | $0.22B | $0.13B | 56.31% |
| 2012-02-29 | $0.22B | $0.13B | 57.27% |
| 2011-11-30 | $0.22B | $0.13B | 57.85% |
| 2011-08-31 | $0.22B | $0.13B | 58.72% |
| 2011-05-31 | $0.22B | $0.13B | 58.33% |
| 2011-02-28 | $0.22B | $0.13B | 58.64% |
| 2010-11-30 | $0.22B | $0.13B | 58.53% |
| 2010-08-31 | $0.22B | $0.13B | 58.53% |
| 2010-05-31 | $0.22B | $0.13B | 59.07% |
| 2010-02-28 | $0.21B | $0.13B | 60.10% |
| 2009-11-30 | $0.21B | $0.13B | 60.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.401B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.463B | 83.86 |
| Thermo Fisher Scientific (TMO) | United States | $155.573B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.256B | 29.67 |
| Alcon (ALC) | Switzerland | $42.967B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $42.445B | 48.78 |
| DexCom (DXCM) | United States | $33.345B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.362B | 15.33 |
| Mettler-Toledo (MTD) | United States | $24.800B | 29.49 |
| STERIS (STE) | Ireland | $23.464B | 25.84 |
| Waters (WAT) | United States | $21.120B | 29.80 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.882B | 0.00 |
| Hologic (HOLX) | United States | $14.509B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Penumbra (PEN) | United States | $9.820B | 77.08 |
| Masimo (MASI) | United States | $9.039B | 33.34 |
| Globus Medical (GMED) | United States | $7.963B | 18.97 |
| Glaukos (GKOS) | United States | $5.775B | 0.00 |
| Teleflex (TFX) | United States | $5.284B | 8.72 |
| TransMedics (TMDX) | United States | $4.399B | 95.63 |
| Integer Holdings (ITGR) | United States | $4.252B | 22.28 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.497B | 14.87 |
| Veracyte (VCYT) | United States | $2.100B | 29.46 |
| Nihon Kohden (NHNKY) | Japan | $2.016B | 23.12 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.593B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.48 |
| Tandem Diabetes Care (TNDM) | United States | $1.273B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.002B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.772B | 39.17 |
| SiBone (SIBN) | United States | $0.771B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.650B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.563B | 8.76 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.529B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.526B | 12.32 |
| Delcath Systems (DCTH) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.477B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.433B | 11.51 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.359B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.336B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.42 |
| Biosig Technologies (BSGM) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |